BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26970660)

  • 21. Inhibitory Effect of Orientin on Secretory Group IIA Phospholipase A2.
    Bae JS
    Inflammation; 2015 Aug; 38(4):1631-8. PubMed ID: 25687642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3.
    Ye L; Dickerson T; Kaur H; Takada YK; Fujita M; Liu R; Knapp JM; Lam KS; Schore NE; Kurth MJ; Takada Y
    Bioorg Med Chem Lett; 2013 Jan; 23(1):340-5. PubMed ID: 23164706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of novel 2-pyrazoline analogues with potent anti-inflammatory effect mediated by inhibition of phospholipase A2: Crystallographic, in silico docking and QSAR analysis.
    Lokeshwari DM; Achutha DK; Srinivasan B; Shivalingegowda N; Krishnappagowda LN; Kariyappa AK
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3806-3811. PubMed ID: 28676270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of Human Group IIA-Secreted Phospholipase A2 and THP-1 Monocyte Recruitment by Maslinic Acid.
    Yap WH; Ahmed N; Lim YM
    Lipids; 2016 Oct; 51(10):1153-1159. PubMed ID: 27540737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In Silico and In Vitro Study of the Bromelain-Phytochemical Complex Inhibition of Phospholipase A2 (Pla2).
    Mohamed Tap F; Abd Majid FA; Ismail HF; Wong TS; Shameli K; Miyake M; Ahmad Khairudin NB
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29351216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping of suramin binding sites on the group IIA human secreted phospholipase A2.
    Vieira DS; Aragão EA; Lourenzoni MR; Ward RJ
    Bioorg Chem; 2009 Apr; 37(2):41-5. PubMed ID: 19251299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-based grafting, mutation, and optimization of peptide inhibitors to fit in the active pocket of human secreted phospholipase A2: find new use of old Peptide agents with anti-inflammatory activity.
    Zhan C; Li S; Zhong Q; Zhou D
    Chem Biol Drug Des; 2015 Apr; 85(4):418-26. PubMed ID: 25187416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
    Oslund RC; Gelb MH
    Biochemistry; 2012 Oct; 51(43):8617-26. PubMed ID: 23020658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2-Oxoamide inhibitors of phospholipase A2 activity and cellular arachidonate release based on dipeptides and pseudodipeptides.
    Barbayianni E; Stephens D; Grkovich A; Magrioti V; Hsu YH; Dolatzas P; Kalogiannidis D; Dennis EA; Kokotos G
    Bioorg Med Chem; 2009 Jul; 17(13):4833-43. PubMed ID: 19443224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PX-18 Protects Human Saphenous Vein Endothelial Cells under Arterial Blood Pressure.
    Kupreishvili K; Stooker W; Emmens RW; Vonk ABA; Sipkens JA; van Dijk A; Eijsman L; Quax PH; van Hinsbergh VWM; Krijnen PAJ; Niessen HWM
    Ann Vasc Surg; 2017 Jul; 42():293-298. PubMed ID: 28300679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity.
    Antonopoulou G; Magrioti V; Kokotou MG; Nikolaou A; Barbayianni E; Mouchlis VD; Dennis EA; Kokotos G
    Bioorg Med Chem; 2016 Oct; 24(19):4544-4554. PubMed ID: 27522578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining in silico and in vitro approaches to identification of potent inhibitor against phospholipase A2 (PLA2).
    Chinnasamy S; Selvaraj G; Selvaraj C; Kaushik AC; Kaliamurthi S; Khan A; Singh SK; Wei DQ
    Int J Biol Macromol; 2020 Feb; 144():53-66. PubMed ID: 31838071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the role of protein disulfide isomerase in the retrograde cell transport of secreted phospholipases A2.
    Oberčkal J; Kovačič L; Šribar J; Leonardi A; Dolinar K; Pucer Janež A; Križaj I
    PLoS One; 2015; 10(3):e0120692. PubMed ID: 25763817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, Antiphospholipase A₂, Antiprotease, Antibacterial Evaluation and Molecular Docking Analysis of Certain Novel Hydrazones.
    El-Sayed NN; Alafeefy AM; Bakht MA; Masand VH; Aldalbahi A; Chen N; Fan C; Ben Bacha A
    Molecules; 2016 Dec; 21(12):. PubMed ID: 27918459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of a novel pyrazole series of group X secreted phospholipase A2 inhibitor (sPLA2X) via fragment based virtual screening.
    Chen H; Knerr L; Åkerud T; Hallberg K; Öster L; Rohman M; Österlund K; Beisel HG; Olsson T; Brengdhal J; Sandmark J; Bodin C
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5251-5. PubMed ID: 25316315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural and Thermodynamic Characterization of Protein-Ligand Interactions Formed between Lipoprotein-Associated Phospholipase A2 and Inhibitors.
    Liu Q; Chen X; Chen W; Yuan X; Su H; Shen J; Xu Y
    J Med Chem; 2016 May; 59(10):5115-20. PubMed ID: 27078579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational and in vitro insights on snake venom phospholipase A
    Muthusamy K; Chinnasamy S; Nagarajan S; Sivaraman T
    J Biomol Struct Dyn; 2018 Dec; 36(16):4197-4208. PubMed ID: 29171346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
    Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of type IIA secretory phospholipase A2 inhibits cholesteryl ester transfer protein activity in transgenic mice.
    Hurt-Camejo E; Gautier T; Rosengren B; Dikkers A; Behrendt M; Grass DS; Rader DJ; Tietge UJ
    Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2707-14. PubMed ID: 24115030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suramin inhibits macrophage activation by human group IIA phospholipase A2, but does not affect bactericidal activity of the enzyme.
    Aragão EA; Chioato L; Ferreira TL; de Medeiros AI; Secatto A; Faccioli LH; Ward RJ
    Inflamm Res; 2009 Apr; 58(4):210-7. PubMed ID: 19169647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.